Unibest
← Back to patent-cliff list

CAS 198480-21-6

1-(4-(2-(azepan-1-yl)ethoxy)benzyl)-5-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indole

Codes: BAZE-009

Application context (from source-drug indications)

Oestrogen deficiency syndromeConjugated Estrogens/Bazedoxifene AcetateOsteoporosisConjugated Estrogens/Bazedoxifene AcetateVasomotor symptomsConjugated Estrogens/Bazedoxifene AcetateNon-invasive ductal carcinomaConjugated Estrogens/Bazedoxifene AcetateAnxietyConjugated Estrogens/Bazedoxifene AcetateMenopausal symptomsConjugated Estrogens/Bazedoxifene AcetatePostmenopausal osteoporosisBazedoxifene AcetateBreast cancerBazedoxifene AcetateOsteoporosisBazedoxifene AcetateMenopausal symptomsBazedoxifene Acetate

Source drugs (routes using this intermediate)

DrugTierExpiry
Conjugated Estrogens/Bazedoxifene AcetateTier C — Watch / trade-
Bazedoxifene AcetateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Conjugated Estrogens/Bazedoxifene AcetateOptimised routesteps: 2total yield: 2 g
1-(4-(2-(azepan-1-yl)ethoxy)benzyl)-5-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indole→1-(2-(4-((1-(4-(benzyloxy)phenyl)hydrazinyl)methyl)phenoxy)ethyl)azepane→1-(benzyloxy)-4-(prop-1-yn-1-yl)benzene
Bazedoxifene AcetateOptimised routesteps: 5total yield: 1.6 g
Bazedoxifene AcetateOptimised routesteps: 2total yield: 2 g
1-(4-(2-(azepan-1-yl)ethoxy)benzyl)-5-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indole→1-(2-(4-((1-(4-(benzyloxy)phenyl)hydrazinyl)methyl)phenoxy)ethyl)azepane→1-(benzyloxy)-4-(prop-1-yn-1-yl)benzene

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.